Legal Representation
Attorney
Mary L. Kevlin, Esq.
USPTO Deadlines
Next Deadline
452 days remaining
Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2016-10-04)
Due Date
October 04, 2026
Grace Period Ends
April 04, 2027
Application History
45 eventsDate | Code | Type | Description |
---|---|---|---|
Apr 12, 2023 | C15A | O | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
Apr 12, 2023 | NA85 | E | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED |
Apr 10, 2023 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
Sep 30, 2022 | E815 | I | TEAS SECTION 8 & 15 RECEIVED |
Oct 4, 2021 | REM1 | E | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
Oct 4, 2016 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
Aug 30, 2016 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
Aug 28, 2016 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
Aug 4, 2016 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE |
Jul 13, 2016 | EISU | I | TEAS STATEMENT OF USE RECEIVED |
Jul 13, 2016 | IUAF | S | USE AMENDMENT FILED |
Mar 30, 2016 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Feb 20, 2016 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Feb 19, 2016 | EX2G | S | SOU EXTENSION 2 GRANTED |
Feb 12, 2016 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
Jan 8, 2016 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
Jan 8, 2016 | EXT2 | S | SOU EXTENSION 2 FILED |
Jul 2, 2015 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Jun 30, 2015 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
Jun 30, 2015 | EXT1 | S | SOU EXTENSION 1 FILED |
Jun 30, 2015 | EX1G | S | SOU EXTENSION 1 GRANTED |
Jan 13, 2015 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Nov 18, 2014 | PUBO | A | PUBLISHED FOR OPPOSITION |
Nov 18, 2014 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Oct 29, 2014 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Oct 10, 2014 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED |
Oct 8, 2014 | ALIE | A | ASSIGNED TO LIE |
Sep 23, 2014 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
Sep 23, 2014 | GNEA | O | EXAMINERS AMENDMENT E-MAILED |
Sep 23, 2014 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Sep 23, 2014 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
Sep 23, 2014 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
Apr 9, 2014 | CNRT | R | NON-FINAL ACTION WRITTEN |
Apr 9, 2014 | GNRT | O | NON-FINAL ACTION E-MAILED |
Apr 9, 2014 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Feb 13, 2014 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Feb 13, 2014 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Feb 13, 2014 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
Sep 8, 2013 | CNRT | R | NON-FINAL ACTION WRITTEN |
Sep 8, 2013 | GNRT | F | NON-FINAL ACTION E-MAILED |
Sep 8, 2013 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Aug 31, 2013 | DOCK | D | ASSIGNED TO EXAMINER |
May 23, 2013 | MDSM | E | NOTICE OF DESIGN SEARCH CODE E-MAILED |
May 22, 2013 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
May 17, 2013 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 035
Consulting in the fields of healthcare operations management, medical practice management, control of healthcare costs and hospital operations management; Business consulting and management in the field of clinical trials or observational studies, namely, management and compilation of private and public computerized databases in the field of clinical trials or observational studies for business purposes; Business consulting services in the field of general health planning and delivery
First Use Anywhere:
May 31, 2013
First Use in Commerce:
May 31, 2013
Class 042
Scientific study and research in the fields of epidemiology, public health, health policy, medicine, the prevention, treatment and management of illness, and health care delivery; Consulting services in the fields of medical research, namely, with respect to research design and planning, statistical and simulation modeling, and the evaluation of diagnostics and pharmacogenomics programs and products of others; Quality evaluation services for the medical industry, namely, evaluation of physician practice operations and quality improvement initiatives for purposes of quality measurement and analysis
First Use Anywhere:
May 31, 2013
First Use in Commerce:
May 31, 2013
Additional Information
Design Mark
The mark consists of the stylized letters and words "R & EA RESEARCH AND EVALUATION ANALYTICS" and the "R" in "R & EA" has an exclamation point at the left hand part of the letter.
Color Claim
Color is not claimed as a feature of the mark.
Pseudo Mark
R AND EA RESEARCH AND EVALUATION ANALYTICS
Classification
International Classes
035
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"ANALYTICS"